Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Caron

Showing results (221-230 of 248) with videos related to

Pageof 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2015
Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent NeuroblastomaM Emmy M Dolman, Evon Poon, Marli E Ebus, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2017
3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patientsI R N Verly, A B P van Kuilenburg, N G G M Abeling, et al.
Frontiers in Oncology|March 10, 2023
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastomaThomas F Eleveld, Lindy Vernooij, Linda Schild, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood CancerElizabeth A M Feijen, Wendy M Leisenring, Kayla L Stratton, et al.
International Journal of Radiation Oncology, Biology, Physics|June 22, 2016
Risk of Symptomatic Stroke After Radiation Therapy for Childhood Cancer: A Long-Term Follow-Up Cohort AnalysisIrma W E M van Dijk, Helena J H van der Pal, Rob M van Os, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2012
Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivorsIrma W E M van Dijk, Mathilde C Cardous-Ubbink, Helena J H van der Pal, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2013
The development of a clinical screening instrument for tumour predisposition syndromes in childhood cancer patientsSaskia M J Hopman, Johannes H M Merks, Corianne A J M de Borgie, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2014
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosisGitta Bleeker, Berthe L van Eck-Smit, Koos H Zwinderman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2018
Peripheral Stem Cell Apheresis is Feasible Post <sup>131</sup>Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet ReconstitutionKathelijne C J M Kraal, Ilse Timmerman, Hannah M Kansen, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|August 22, 2015
Hearing loss in survivors of childhood head and neck rhabdomyosarcoma: a long-term follow-up studyR A Schoot, E A R Theunissen, O Slater, et al.
Pageof 25

Showing results (221-230 of 248) with videos related to

Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2015
Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent NeuroblastomaM Emmy M Dolman, Evon Poon, Marli E Ebus, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2017
3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patientsI R N Verly, A B P van Kuilenburg, N G G M Abeling, et al.
Frontiers in Oncology|March 10, 2023
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastomaThomas F Eleveld, Lindy Vernooij, Linda Schild, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood CancerElizabeth A M Feijen, Wendy M Leisenring, Kayla L Stratton, et al.
International Journal of Radiation Oncology, Biology, Physics|June 22, 2016
Risk of Symptomatic Stroke After Radiation Therapy for Childhood Cancer: A Long-Term Follow-Up Cohort AnalysisIrma W E M van Dijk, Helena J H van der Pal, Rob M van Os, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2012
Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivorsIrma W E M van Dijk, Mathilde C Cardous-Ubbink, Helena J H van der Pal, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2013
The development of a clinical screening instrument for tumour predisposition syndromes in childhood cancer patientsSaskia M J Hopman, Johannes H M Merks, Corianne A J M de Borgie, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2014
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosisGitta Bleeker, Berthe L van Eck-Smit, Koos H Zwinderman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2018
Peripheral Stem Cell Apheresis is Feasible Post <sup>131</sup>Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet ReconstitutionKathelijne C J M Kraal, Ilse Timmerman, Hannah M Kansen, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|August 22, 2015
Hearing loss in survivors of childhood head and neck rhabdomyosarcoma: a long-term follow-up studyR A Schoot, E A R Theunissen, O Slater, et al.
Pageof 25